The Russian government decided to provide a subsidy from the federal budget to NPO Microgen for the reconstruction and technical re-equipment of its production facilities for influenza vaccines in 2018-2021.
The estimated cost of capital construction facility is 7,977,390 thousand rubles; the capacity to be commissioned is 20,003.1 square meters; and the commissioning is scheduled for 2021.
This project will be implemented as part of the state program of the Russian Federation “Development of Pharmaceutical and Medical industry” for 2013-2020.
The completion of the project on Building No. 12: Reconstruction and Technical Re-Equipment, Organization of Production Facility for Influenza Vaccines will allow to:
- ensure national epidemiological safety in the prevention of influenza by increasing the output of Russian influenza vaccines up to 35 million doses a year by 2023, inclusive;
- increase exports of Russian influenza vaccines
- up to 194 million rubles by 2025, inclusive;
- create up to 187 new high-tech jobs by 2023, inclusive.